Literature DB >> 12103291

A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis.

James R Johnson1, Amee R Manges, Timothy T O'Bryan, Lee W Riley.   

Abstract

In acute pyelonephritis, bacterial resistance to co-trimoxazole predicts treatment failure, but the clonal basis of such resistance is undefined. We did molecular and serological analyses of 170 Escherichia coli urine isolates obtained in 1994-96 from women with acute pyelonephritis. 12 (7%) of the pyelonephritis isolates were in clonal group A (CGA; responsible for 38-51% of co-trimoxazole resistance in acute cystitis), including ten (34%) of 29 isolates that were resistant to co-trimoxazole. CGA isolates were obtained from diverse locations across the USA and were related to the O15:K52:H1 clone of the 1986-87 outbreak in London, UK. Thus, CGA is broadly disseminated and contributes to co-trimoxazole resistance in pyelonephritis as well as in cystitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12103291     DOI: 10.1016/S0140-6736(02)09264-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

1.  Detection of clonal group A Escherichia coli isolates from broiler chickens, broiler chicken meat, community-dwelling humans, and urinary tract infection (UTI) patients and their virulence in a mouse UTI model.

Authors:  Lotte Jakobsen; Anette M Hammerum; Niels Frimodt-Møller
Journal:  Appl Environ Microbiol       Date:  2010-10-29       Impact factor: 4.792

2.  A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal:  Vaccine       Date:  2007-02-05       Impact factor: 3.641

3.  Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'bryan; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection.

Authors:  James R Johnson; Connie Clabots; Henry Rosen
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Sujay Chattopadhyay; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  Antibiotic prophylaxis by low-dose cefaclor in children with vesicoureteral reflux.

Authors:  Kazunari Kaneko; Yoshiyuki Ohtomo; Toshiaki Shimizu; Yuichiro Yamashiro; Atsuyuki Yamataka; Takeshi Miyano
Journal:  Pediatr Nephrol       Date:  2003-04-03       Impact factor: 3.714

7.  Use of fimH single-nucleotide polymorphisms for strain typing of clinical isolates of Escherichia coli for epidemiologic investigation.

Authors:  Rubens C S Dias; Beatriz M Moreira; Lee W Riley
Journal:  J Clin Microbiol       Date:  2009-12-16       Impact factor: 5.948

8.  Occurrence of antibiotic-resistant uropathogenic Escherichia coli clonal group A in wastewater effluents.

Authors:  Laura A Boczek; Eugene W Rice; Brian Johnston; James R Johnson
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

9.  Enteroaggregative Escherichia coli related to uropathogenic clonal group A.

Authors:  Faith Wallace-Gadsden; James R Johnson; John Wain; Iruka N Okeke
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

10.  Food reservoir for Escherichia coli causing urinary tract infections.

Authors:  Caroline Vincent; Patrick Boerlin; Danielle Daignault; Charles M Dozois; Lucie Dutil; Chrissi Galanakis; Richard J Reid-Smith; Pierre Paul Tellier; Patricia A Tellis; Kim Ziebell; Amee R Manges
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.